These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 2232208
21. Graft-versus-leukemia reactions following bone marrow transplantation for chronic myeloid leukemia. Mackinnon S. Prog Clin Biol Res; 1992; 377():113-25; discussion 126-7. PubMed ID: 1438407 [No Abstract] [Full Text] [Related]
22. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E. Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333 [Abstract] [Full Text] [Related]
23. Graft-versus-leukaemia after bone marrow transplantation. Barret AJ. Pediatr Med Chir; 1991 Jul; 13(1):9-13. PubMed ID: 2052462 [No Abstract] [Full Text] [Related]
24. Effect of selective donor T-cell depletion on the graft-versus-leukemia reaction in allogeneic marrow transplantation. OKunewick J, Kociban D, Machen L, Buffo M. Transplant Proc; 1992 Dec; 24(6):2998-9. PubMed ID: 1361270 [No Abstract] [Full Text] [Related]
25. [Emergency problems of the graft vs host reaction (literature survey)]. Shevelev AS. Probl Gematol Pereliv Krovi; 1976 Apr; 21(4):35-41. PubMed ID: 16257 [No Abstract] [Full Text] [Related]
26. Genetic factors influence the development of acute graft-versus-host disease in adults undergoing allogeneic bone marrow transplantation. Smyth LA, Herrmann RP, Christiansen FT, Witt CS, Townend DC, Dawkins RL. Transplant Proc; 1992 Oct; 24(5):2269. PubMed ID: 1413052 [No Abstract] [Full Text] [Related]
27. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J, Gratwohl A, Vogelsang GB, van Houwelingen HC, van Rood JJ. N Engl J Med; 1996 Feb 01; 334(5):281-5. PubMed ID: 8532022 [Abstract] [Full Text] [Related]
28. The quest for a bone marrow donor--optimal or maximal HLA matching? van Rood JJ, Oudshoorn M. N Engl J Med; 1998 Oct 22; 339(17):1238-9. PubMed ID: 9780345 [No Abstract] [Full Text] [Related]
29. Induction of graft-versus-leukemia effect in a patient with chronic lymphocytic leukemia. deMagalhaes-Silverman M, Donnenberg A, Hammert L, Lister J, Myers D, Simpson J, Ball E. Bone Marrow Transplant; 1997 Jul 22; 20(2):175-7. PubMed ID: 9244424 [Abstract] [Full Text] [Related]
30. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. Pelot MR, Pearson DA, Swenson K, Zhao G, Sachs J, Yang YG, Sykes M. Biol Blood Marrow Transplant; 1999 Jul 22; 5(3):133-43. PubMed ID: 10392959 [Abstract] [Full Text] [Related]
31. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. Farag SS, Bacigalupo A, Eapen M, Hurley C, Dupont B, Caligiuri MA, Boudreau C, Nelson G, Oudshoorn M, van Rood J, Velardi A, Maiers M, Setterholm M, Confer D, Posch PE, Anasetti C, Kamani N, Miller JS, Weisdorf D, Davies SM, KIR Study Group, Center for International Blood and Marrow Transplantation Research. Biol Blood Marrow Transplant; 2006 Aug 22; 12(8):876-84. PubMed ID: 16864058 [Abstract] [Full Text] [Related]
33. [Immunochemical monitoring after bone marrow transplantation]. Uvarov MA, Okulov VB, Afanas'ev BV, Karetkina EI. Ter Arkh; 1996 Apr 22; 68(7):14-7. PubMed ID: 8928065 [No Abstract] [Full Text] [Related]
34. The role of cytokines in graft-versus-host reactions and disease. Jadus MR, Wepsic HT. Bone Marrow Transplant; 1992 Jul 22; 10(1):1-14. PubMed ID: 1515873 [Abstract] [Full Text] [Related]
35. [Use of monoclonal antibodies for the prevention of graft-versus-host and host-versus-graft reaction in allogenic bone marrow grafts]. Hervé P. Nephrologie; 1987 Jul 22; 8(3):103-8. PubMed ID: 3309699 [Abstract] [Full Text] [Related]
36. [Graft versus host reaction--serious threat in bone marrow transplantation]. Boström L. Lakartidningen; 1992 Jul 22; 89(30-31):2505-7. PubMed ID: 1507980 [No Abstract] [Full Text] [Related]
37. Veto cells are not responsible for alloimmunization-induced abrogation of lethal graft-versus-host reaction. Halle-Pannenko O, Bruley-Rosset M, Pritchard LL. Transplant Proc; 1987 Feb 22; 19(1 Pt 1):549-50. PubMed ID: 2978923 [No Abstract] [Full Text] [Related]
39. The use of polymerase chain reaction (PCR) gene amplification and synthetic oligonucleotide probes for HLA-DP typing in bone marrow transplantation. Howell WM, Evans PR, Sage DA, Lambert CM, Wilson PJ, Smith JL. Bone Marrow Transplant; 1990 Jan 22; 5(1):66-7. PubMed ID: 2297593 [No Abstract] [Full Text] [Related]
40. Major histocompatibility complex influences the development of acute graft-versus-host disease in MHC-matched adult allogeneic bone marrow transplantation. Smyth LA, Herrmann RP, Christiansen FT, Hollingsworth PN, Townend DC, Edward E, Dawkins RL. Transplant Proc; 1993 Feb 22; 25(1 Pt 2):1276-8. PubMed ID: 8442111 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]